1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. Saudi Arabia Continuous Glucose Monitoring Market BY Application
5.1. Introduction
5.2. Diabetes Patients
5.3. Critical Patients
6. Saudi Arabia Continuous Glucose Monitoring Market BY Component
6.1. Introduction
6.2. Sensors
6.3. Transmitters
6.4. Receivers/Monitors
7. Saudi Arabia Continuous Glucose Monitoring Market BY End-User Industry
7.1. Introduction
7.2. Hospitals
7.3. Diagnostic Centers & Clinics
7.4. Home Care
8. COMPETITIVE ENVIRONMENT AND ANALYSIS
8.1. Major Players and Strategy Analysis
8.2. Market Share Analysis
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Competitive Dashboard
9. COMPANY PROFILES
9.1. Sanofi S. A
9.2. Johnson & Johnson
9.3. Abbott Laboratories
9.4. Medtronic plc
9.5. Dexcom, Inc.
9.6. Roche Diabetes Care, Inc.
9.7. Insulet Corporation
9.8. Ypsomed AG
9.9. Novo Nordisk A/S
9.10. Bayer Saudi Arabia LLC
10. APPENDIX
10.1. Currency
10.2. Assumptions
10.3. Base and Forecast Years Timeline
10.4. Key benefits for the stakeholders
10.5. Research Methodology
10.6. Abbreviations